Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

The Next Wave of Diabetes Dominance
Motley Fool
Wed, 12/12/12 - 08:11 am
Tags:
diabetes, Bayer, Sanofi, Novo Nordisk, Abbott Labs, Bristol-Myers Squibb
Sanofi's last on the list to buy Bayer's glucose devices
Mass Device
Mon, 12/10/12 - 12:08 pm
Tags:
Sanofi, M&A, Bayer, diabetes
Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
Yahoo/PR Newswire
Sun, 12/9/12 - 11:32 am
Tags:
Sanofi, myelofibrosis, SAR302503
7 Upcoming Biotech Catalysts For Year-End 2012 And Early 2013
Seeking Alpha
Fri, 12/7/12 - 11:45 am
Tags:
Alexza, BiogenIdec, Celsion, Celgene, Sanofi, JNJ, Threshold Pharmaceuticals
Bayer diabetes unit sale unlikely - sources
Reuters
Fri, 12/7/12 - 10:37 am
Tags:
Bayer, diabetes, M&A, Sanofi
Roche, Pfizer, Sanofi Plan $72.7 Million Stem-Cell Bank
Bloomberg Businessweek
Wed, 12/5/12 - 12:15 pm
Tags:
Roche, Pfizer, stem cells, Sanofi
Big Pharma Sees More Approvals, Disappointing Revenues: Healthcare Business Update
Wall St. Cheat Sheet
Wed, 12/5/12 - 10:06 am
Tags:
drug approvals, Pfizer, Merck, GSK, Sanofi, Roche
This Drug Helps Investors Rest Easy
Motley Fool
Sun, 12/2/12 - 12:02 pm
Tags:
suvorexant, Merck, insomnia, hypnotics, Sanofi, Ambien
Amarin Is Really Good At Delays, Drug Launches Not So Much
TheStreet.com
Thu, 11/29/12 - 10:42 am
Tags:
Amarin, Vascepa, drug launches, Celgene, Sanofi
10 top drug launch disasters
Fierce Pharma
Wed, 11/28/12 - 11:13 am
Tags:
drug launches, Rare Disease Therapeutics, Anascorp, AstraZeneca, Brilinta, Somaxon, Silenor, Sanofi, Multaq, Savient, Krystexxa, XenoPort, Horizant, Human Genome Sciences, Benlysta, Zaltrap, Dendreon, Provenge, KV Pharmaceutical, Makena
Investing in a better flu shot
Markewatch
Tue, 11/27/12 - 10:29 am
Tags:
vaccines, Flu, GSK, AstraZeneca, Sanofi
This Week in Biotech
Motley Fool
Sun, 11/25/12 - 11:15 am
Tags:
Arena, Vivus, Regeneron, Sanofi, MAP Pharmaceuticals, Allergan
Celgene, Sanofi Executives Charged With Insider Trading
Bloomberg
Wed, 11/21/12 - 02:17 pm
Tags:
Celgene, Sanofi, Management, legal, insider trading, stock
Overnight success proves elusive for oral MS drugs
Fierce Pharma
Tue, 11/20/12 - 01:25 pm
Tags:
multiple sclerosis, MS, Novartis, Gilenya, Sanofi, Aubagio
Novo Nordisk A/S: Catching The Increasing Diabetes Trend
Seeking Alpha
Tue, 11/20/12 - 11:27 am
Tags:
diabetes, Novo Nordisk, Bristol-Myers Squibb, Eli Lilly, Sanofi
This Top-Dollar Drug Hits the Discount Rack
Motley Fool
Sat, 11/17/12 - 01:27 pm
Tags:
Sanofi, Dendreon, Regeneron, Zaltrap
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Fri, 11/16/12 - 10:43 am
Tags:
Sanofi, Europe, diabetes, Zaltrap, colorectal cancer, Lyxumia
Teva Is Still Healthier Than Its Big Pharma Peers
Seeking Alpha
Thu, 11/15/12 - 10:47 am
Tags:
Teva, AstraZeneca, Bristol-Myers Squibb, GSK, JNJ, Merck, Novo Nordisk, Novartis, Pfizer, Sanofi
'Super' Novavax: Company Outshines Stars Of Pandemic Influenza Vaccine Production
Seeking Alpha
Wed, 11/14/12 - 11:13 am
Tags:
Novavax, Flu, vaccines, GSK, Merck, Novartis, Sanofi
Prostate Cancer Market Takes Shape - Part 1: Dendreon And Medivation
Seeking Alpha
Wed, 11/14/12 - 10:33 am
Tags:
prostate cancer, Medivation, Dendreon, Provenge, JNJ, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.